CBD Market expected to reach $22 Billion by 2022, overtaking cannabis
Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) was featured recently in an Investorideas.com article. The report referenced the findings of analysts at Brightfield Group that shows the CBD market is expected to reach $22 billion by 2022 overtaking the cannabis market’s $20 billion projected for 2020. The point of the article is that as this happens, product branding will be essential.
What caught my attention is the fact that the companies on their list included Tilray (NASDAQ: TLRY) and Green Growth Brands (CSE: GGB) that each have separate agreements with Authentic Brands Group, The Supreme Cannabis Company, Inc. (TSXV: FIRE.V) working through their wholly-owned subsidiary 7ACRES and my personal favorite, and their recent agreement with Dixie Brands Inc. (CSE: DIXI.U) that is in good company being included in this group.
KHRN, as mentioned here recently, will set up a 50/50 joint venture that will introduce a full line of cannabis infused products from DIXI into the Latin American market while DIXI will manufacture and market KHRN’s Kuida® brand of CBD-based cosmeceuticals to the nearly 60 million Hispanics living in the U.S. isn’t ignoring. Khiron and Dixie Brands Inc.
Don’t fall asleep at the switch on Khiron. It’s a small but rapidly growing cannabis company with a tremendous management team that seem to be pushing all the right buttons to secure a much larger position in the international cannabis space. 2019 promises to be a big year for KHRN as it begins to report substantial increases in revenue. With revenue comes recognition and investor awareness. Investor awareness augers well for those who own Khiron (CSE: KHRN) at current levels.